Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patients with Plaque Psoriasis
Stock Information for Crescita Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.